Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Breast Cancer
18 articles
Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
NOBROLA Trial: Olaparib Shows Promise in Rare TNBC Subset Despite Low Enrollment
Phase II trial explores olaparib in TNBC patients with HRD but no BRCA mutations, showing potential benefit.
Unmasking the Risk Factors: New Insights into Immune-Mediated Hepatotoxicity in Cancer Immunotherapy
Meta-analysis reveals key risk factors for liver toxicity in cancer patients receiving immunotherapy
Intensified Chemo Falls Short in Oligometastatic Breast Cancer Study
IACT shows no advantage over CDCT in HRD-positive oligometastatic breast cancer, but long-term survival promising
Neoadjuvant Endocrine Therapy Reduces Mastectomy Rates in Early Breast Cancer
Meta-analysis shows neoadjuvant endocrine therapy lowers mastectomy rates in ER-positive early breast cancer.
Genetic Variants Linked to Higher Mortality Risk in Cancer Chemotherapy
Meta-analysis reveals DPYD gene variants significantly increase death risk in fluoropyrimidine chemotherapy.
Acupressure: A Promising Complementary Therapy for Chemotherapy-Induced Nausea in Breast Cancer
Study shows acupressure reduces chemotherapy-induced nausea and vomiting in breast cancer patients.
Promising Brain Breakthrough: T-DXd Shows Hope for HER2-Low Breast Cancer with Brain Metastases
T-DXd demonstrates encouraging intracranial activity in HER2-low breast cancer patients with brain metastases.
Warming Up to Scalp Cooling: Electric Hand Warmers Boost Comfort for Breast Cancer Patients
Study shows electric hand warmers improve comfort for breast cancer patients using scalp cooling during chemo
Lower Dose Olanzapine: A Game-Changer for Chemo Nausea Prevention
Study finds lower olanzapine dose equally effective for chemo-induced nausea with less drowsiness.
Pembrolizumab Boosts Early TNBC Outcomes in Asian Patients: KEYNOTE-522 Subanalysis
Immunotherapy improves pathological complete response and event-free survival in Asian TNBC patients.
Novel Oral SERD Shows Promise in Early-Stage Breast Cancer Study
Amcenestrant demonstrates antiproliferative effects and ER degradation in ER+/HER2- breast cancer patients.